The emergence of amoebic dysentery mimicking COVID-19: A human case report from Iran
Abstract
Identical symptoms of coronavirus disease-19 (COVID-19) with infectious and non-infectious disease have become challenging issue for health professions. In the present study, we describe a human case of amoebic dysentery mimicking severe acute respiratory syndrome coronavirus 2 (SARS−CoV-2) infection in Iran with an emphasis on morphological and molecular diagnostic aspects of Entamoeba histolytica parasite. A 32-year-old woman with a history of abdominal pain, diarrhea, and mild fever of 38°C was diagnosed as COVID-19 with no prescription of real-time RT-PCR. The patient was prescribed having azithromycin 500 mg/day for 5 days. Her later aggravated conditions such as fulminant dysentery has led to the diagnosis of E. histolytica with parasitological and molecular methods. SARS-CoV-2 infection was ruled out in the second visit using real-time RT-PCR and ELISA. Treatment was completed with antiparasitic drugs including oral metronidazole 500 mg, 3 times/day for ten days, and oral iodoquinol 650 mg 3 times/day for twenty days. In general, health professions must be vigilant in all aspects of diagnosis, treatment, and management of patients to prevent any medical errors and misdiagnosis.
Keywords
Full Text:
Full-text PDFReferences
Hui DS, E IA, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020; 91:264-6.
Hiscott J, Alexandridi M, Muscolini M, Tassone E, Palermo E, Soultsioti M, et al. The global impact of the coronavirus pandemic. Cytokine Growth Factor Rev. 2020; 53:1-9.
Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020; 26(7):1017-32.
Chacon-Cruz E, Mitchell D. Intestinal protozoal diseases. Medicine Journal. 2003;3(5):1-1.
Henrina J, Putra ICS, Lawrensia S, Handoyono QF, Cahyadi A. Coronavirus Disease of 2019: a Mimicker of Dengue Infection? SN Compr Clin Med. 2020; 2(8):1109-19.
Amano K, Takeuchi T. Amebiasis in acquired immunodeficiency syndrome. Intern Med. 2001; 40(7):563-4.
Ikbal AMA, Debnath B, Rajkhowa A, Paul K, Majumder R, Manna K. Amoebiasis: An Infectious Disease Caused by Entamoeba histolytica. Asian J of Basic Sci Res. 2022; 4(2):32-40.
Haghighi A, Riahi SM, Taghipour A, Spotin A, Javanian M, Mohammadi M, et al. Amoebiasis in Iran: a systematic review and meta-analysis. Epidemiol Infect. 2018; 146(15):1880-90.
Mohebali M, Keshavarz H, Abbaszadeh Afshar MJ, Hanafi-Bojd AA, Hassanpour G. Spatial Distribution of Common Pathogenic Human Intestinal Protozoa in Iran: A Systematic Review. Iran J Public Health. 2021; 50(1):69-82.
Singhi S, Chaudhary D, Varghese GM, Bhalla A, Karthi N, Kalantri S, et al. Tropical fevers: Management guidelines. Indian J Crit Care Med. 2014; 18(2):62-9.
Hussein MIH, Albashir AAD, Elawad O, Homeida A. Malaria and COVID-19: unmasking their ties. Malar J. 2020; 19(1):457.
Nacher M, Douine M, Gaillet M, Flamand C, Rousset D, Rousseau C, et al. Simultaneous dengue and COVID-19 epidemics: Difficult days ahead? PLoS Negl Trop Dis. 2020; 14(8):e0008426.
Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020; 46(5):854-87.
Martins-Filho PR, Tavares CSS, Santos VS. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. Eur J Intern Med. 2020; 76:97-9.
Dave TV, Gopinathan Nair A, Hegde R, Vithalani N, Desai S, Adulkar N, et al. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study. Ophthalmic Plast Reconstr Surg. 2021; 37(5):488-95.
Hays R, Pierce D, Giacomin P, Loukas A, Bourke P, McDermott R. Helminth coinfection and COVID-19: An alternate hypothesis. PLoS Negl Trop Dis. 2020; 14(8):e0008628.
Nakhaei M, Fakhar M, Sharifpour A, Banimostafavi ES, Zakariaei Z, Mehravaran H, et al. First Co-morbidity of Lophomonas blattarum and COVID-19 Infections: Confirmed Using Molecular Approach. Acta Parasitol. 2022; 67(1):535-8.
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 © The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.